MEPSGEN
PrivateLast Round
Series C
Nov 19, 2024
Total Funding Raised
$22.87M
Momentum Score
25 /100
Company Overview
MEPSGEN is a biotechnology company that develops human microphysiological systems (organ-on-a-chip) and nanoparticle synthesis platforms to aid in drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MEPSGEN Comps
Public and private peers based on sector, stage, and business model.
MEPSGEN Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 19, 2024 | ||||
| Series B | Jul 13, 2022 |
MEPSGEN Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KIWOOM Securities Co., Ltd. | Series B |
| Kolon Investment | Series B |
| Yuanta Investment | Series C |
| Korea Development Bank | Series C, Series B |
| KB-SOLIDUS Healthcare Investment Fund | Series C |
| E&Investment | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2025
Professor Choi Nak-won joins as new CSO.
MEPSGEN Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MEPSGEN's valuation, stock price, and market status.
